These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16278330

  • 1. I.V. admixture contamination rates: traditional practice site versus a class 1000 cleanroom.
    Thomas M, Sanborn MD, Couldry R.
    Am J Health Syst Pharm; 2005 Nov 15; 62(22):2386-92. PubMed ID: 16278330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P, Elia M.
    J Hosp Infect; 2013 Feb 15; 83(2):160-3. PubMed ID: 23313030
    [Abstract] [Full Text] [Related]

  • 5. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C, Sautter AM, Favet J, Bonnabry P.
    Am J Health Syst Pharm; 2009 Nov 15; 66(22):2032-6. PubMed ID: 19890087
    [Abstract] [Full Text] [Related]

  • 6. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators.
    Sigward E, Fourgeaud M, Vazquez R, Guerrault-Moro MN, Brossard D, Crauste-Manciet S.
    Am J Health Syst Pharm; 2012 Jul 15; 69(14):1218-24. PubMed ID: 22761076
    [Abstract] [Full Text] [Related]

  • 7. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I, Federici M, Kaiser V, Thiesen J.
    J Oncol Pharm Pract; 2016 Apr 15; 22(2):195-204. PubMed ID: 25549919
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures.
    Sanders LH, Mabadeje SA, Avis KE, Cruze CA, Martinez DR.
    Am J Hosp Pharm; 1978 May 15; 35(5):531-6. PubMed ID: 350042
    [Abstract] [Full Text] [Related]

  • 12. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding.
    Trissel LA, Gentempo JA, Anderson RW, Lajeunesse JD.
    Am J Health Syst Pharm; 2005 Feb 01; 62(3):285-8. PubMed ID: 15719586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL, Latiolais CJ, Schneider PJ, Moore TD, Buesching WJ, Wentworth BC.
    Am J Hosp Pharm; 1981 Aug 01; 38(8):1144-7. PubMed ID: 7270557
    [Abstract] [Full Text] [Related]

  • 15. Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.
    Krämer I, Federici M.
    Eur J Hosp Pharm; 2020 Jul 01; 27(4):209-215. PubMed ID: 32587079
    [Abstract] [Full Text] [Related]

  • 16. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ, Leclercq GM, Wouters DM, Halbardier L, Hammad C, Kassoul N.
    J Oncol Pharm Pract; 2015 Apr 01; 21(2):118-27. PubMed ID: 24567041
    [Abstract] [Full Text] [Related]

  • 17. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH, Franssen EJF, Pilesi F, Crul M.
    Eur J Pharm Sci; 2019 Mar 15; 130():181-185. PubMed ID: 30710619
    [Abstract] [Full Text] [Related]

  • 18. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF, McKeon MR, Weiss WT.
    Am J Health Syst Pharm; 2007 Mar 15; 64(6):622-31. PubMed ID: 17353571
    [Abstract] [Full Text] [Related]

  • 19. Potential for microbial contamination of ADD-Vantage admixtures.
    Hudson TJ, Ambroziak EM, Coley RM.
    J Pharm Technol; 1992 Mar 15; 8(5):195-7. PubMed ID: 10121013
    [Abstract] [Full Text] [Related]

  • 20. Control of the aseptic processing environment.
    Frieben WR.
    Am J Hosp Pharm; 1983 Nov 15; 40(11):1928-35. PubMed ID: 6650522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.